Economic Issues of Chronic Kidney Disease and End-Stage Renal Disease
- PMID: 30991413
- DOI: 10.1159/000496533
Economic Issues of Chronic Kidney Disease and End-Stage Renal Disease
Abstract
Background: With the growth in the global economy, the number of patients worldwide undergoing renal replacement therapy such as hemodialysis is increasing by 6-7% annually. Accordingly, medical costs for the treatment of chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD) as well as for renal replacement therapy have become a major issue.
Summary: It has been reported that in the United States, the annual medical cost for a patient with CKD is approximately USD 20,000, and that the total medical cost for a CKD patient is higher than that of an ESRD patient [<xref ref-type="bibr" rid="ref1">1</xref>]. In the present study, we found that the medical costs for renal replacement therapy (RRT) in Japan are reasonable compared to those in the United States and Europe. Key Messages: The medical costs for RRT in Japan are reasonable and are not a major issue in Japan.
© 2019 S. Karger AG, Basel.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous